Pre-Clinical Biomarker Validation & Translational Research
Value proposition
Test/monitor target engagement or off-target effects in the brain. Help determine effective and safe doses. Define the therapeutic window in humans.
Key Services
Detection & quantification of biomarkers within NDEs.
Customization of exosome-based assay for specific targets.
Biomarker assay analytical validation and clinical incorporation.
Services list
Target engagement biomarker discovery, development, and validation.
Pathway engagement biomarker discovery, development, and validation.
Off-target/adverse event/safety biomarker discovery, development, and validation.
Why Choose NeuroDex
At NeuroDex, we are committed to advancing the field of neurological diagnostics through cutting-edge biomarker discovery and innovative testing solutions. Our proprietary technologies and research capabilities enable us to deliver precise and reliable insights for early disease detection, monitoring treatment efficacy, and advancing therapeutic research.
Operational Excellence
NeuroDex's operational excellence is built on rigorous quality standards, including GLP and CLIA compliance, ensuring reliable, reproducible, and high-quality biomarker analysis.
Personalized Insights
NeuroDex's personalized insights approach delivers customized biomarker panels designed to precisely detect and monitor disease markers, supporting targeted research and improved patient outcomes.
Scientific Precision
NeuroDex's scientific precision is driven by advanced isolation and detection techniques that ensure accurate biomarker identification, supporting reliable diagnostics and robust research outcomes.
Collaborative Approach
NeuroDex's collaborative approach involves partnering with clinical and research teams to develop tailored biomarker solutions, fostering seamless integration and impactful research outcomes.
Biomarker Discovery Solutions
NeuroDex provides advanced biomarker discovery solutions that integrate seamlessly into clinical workflows. Our neuron-derived extracellular vesicle (NDE) panels enable precise disease detection, monitoring, and treatment evaluation. Validated under GLP and CLIA standards, our solutions support personalized diagnostics, enhance patient care, and optimize therapeutic strategies.
Regulatory Compliance
Clinical Trial Support
Enhanced Diagnostic Accuracy
Personalized Monitoring
Parkinson's disease and synucleopathy
*a-syn biomarker, novel biomarker discovery
ALS
*TDP43 biomarker, novel biomarker discovery
Alzheimer's disease
*Tau/pTau, A-syn, biomarkers, novel biomarker discovery
Neuroinflamation
*NF-kB biomarker, novel biomarker discovery
Autophagy, Brain injury
*LC3 biomarker, novel biomarker discovery